Array Technologies
ARRY
$12.40
Share price
3.85%
Change (1 day)
-39.48%
Change (1 year)
Categories
Array Technologies (ARRY) - Cash on Hand
Cash on Hand as of December 2023 : $0.24 B
According to Array Technologies's latest financial reports the company has $0.24 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Array Technologies - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.24 B | 86.02% |
| 2022-12-31 | $0.13 B | -63.58% |
| 2021-12-31 | $0.36 B | 239.05% |
| 2020-12-31 | $0.10 B | -65.05% |
| 2019-12-31 | $0.31 B | 659.96% |
| 2018-12-31 | $40.82 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $13.96 B | 5,505.43% | 🇨🇭 Switzerland |
 Eli Lilly LLY | $2.92 B | 1,075.41% | 🇺🇸 USA |
 Amgen AMGN | $10.94 B | 4,293.77% | 🇺🇸 USA |
 AstraZeneca AZN | $8.02 B | 3,120.25% | 🇬🇧 UK |
 Onconova Therapeutics ONTX | $25.24 M | -89.87% | 🇺🇸 USA |